Global Antituberculosis Agent-9 Market Growth 2025-2031
The global Antituberculosis Agent-9 market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
United States market for Antituberculosis Agent-9 is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Antituberculosis Agent-9 is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Antituberculosis Agent-9 is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Antituberculosis Agent-9 players cover MedChemExpress, Pfizer Inc., Sanofi S.A., Novartis International AG, GlaxoSmithKline plc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Antituberculosis Agent-9 Industry Forecast” looks at past sales and reviews total world Antituberculosis Agent-9 sales in 2024, providing a comprehensive analysis by region and market sector of projected Antituberculosis Agent-9 sales for 2025 through 2031. With Antituberculosis Agent-9 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antituberculosis Agent-9 industry.
This Insight Report provides a comprehensive analysis of the global Antituberculosis Agent-9 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antituberculosis Agent-9 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antituberculosis Agent-9 market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antituberculosis Agent-9 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antituberculosis Agent-9.
This report presents a comprehensive overview, market shares, and growth opportunities of Antituberculosis Agent-9 market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Antituberculosis Agent-9 market?
What factors are driving Antituberculosis Agent-9 market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Antituberculosis Agent-9 market opportunities vary by end market size?
How does Antituberculosis Agent-9 break out by Type, by Application?
United States market for Antituberculosis Agent-9 is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Antituberculosis Agent-9 is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Antituberculosis Agent-9 is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Antituberculosis Agent-9 players cover MedChemExpress, Pfizer Inc., Sanofi S.A., Novartis International AG, GlaxoSmithKline plc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Antituberculosis Agent-9 Industry Forecast” looks at past sales and reviews total world Antituberculosis Agent-9 sales in 2024, providing a comprehensive analysis by region and market sector of projected Antituberculosis Agent-9 sales for 2025 through 2031. With Antituberculosis Agent-9 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antituberculosis Agent-9 industry.
This Insight Report provides a comprehensive analysis of the global Antituberculosis Agent-9 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antituberculosis Agent-9 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antituberculosis Agent-9 market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antituberculosis Agent-9 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antituberculosis Agent-9.
This report presents a comprehensive overview, market shares, and growth opportunities of Antituberculosis Agent-9 market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Solid State
- Liquid State
- Oral
- Injection
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- MedChemExpress
- Pfizer Inc.
- Sanofi S.A.
- Novartis International AG
- GlaxoSmithKline plc
- Johnson & Johnson
- Lupin Limited
- Otsuka Pharmaceutical Co., Ltd.
- Eli Lilly and Company
- Sandoz International GmbH
- Mylan N.V.
What is the 10-year outlook for the global Antituberculosis Agent-9 market?
What factors are driving Antituberculosis Agent-9 market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Antituberculosis Agent-9 market opportunities vary by end market size?
How does Antituberculosis Agent-9 break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Antituberculosis Agent-9 Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Antituberculosis Agent-9 by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Antituberculosis Agent-9 by Country/Region, 2020, 2024 & 2031
2.2 Antituberculosis Agent-9 Segment by Type
2.2.1 Solid State
2.2.2 Liquid State
2.3 Antituberculosis Agent-9 Sales by Type
2.3.1 Global Antituberculosis Agent-9 Sales Market Share by Type (2020-2025)
2.3.2 Global Antituberculosis Agent-9 Revenue and Market Share by Type (2020-2025)
2.3.3 Global Antituberculosis Agent-9 Sale Price by Type (2020-2025)
2.4 Antituberculosis Agent-9 Segment by Application
2.4.1 Oral
2.4.2 Injection
2.5 Antituberculosis Agent-9 Sales by Application
2.5.1 Global Antituberculosis Agent-9 Sale Market Share by Application (2020-2025)
2.5.2 Global Antituberculosis Agent-9 Revenue and Market Share by Application (2020-2025)
2.5.3 Global Antituberculosis Agent-9 Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Antituberculosis Agent-9 Breakdown Data by Company
3.1.1 Global Antituberculosis Agent-9 Annual Sales by Company (2020-2025)
3.1.2 Global Antituberculosis Agent-9 Sales Market Share by Company (2020-2025)
3.2 Global Antituberculosis Agent-9 Annual Revenue by Company (2020-2025)
3.2.1 Global Antituberculosis Agent-9 Revenue by Company (2020-2025)
3.2.2 Global Antituberculosis Agent-9 Revenue Market Share by Company (2020-2025)
3.3 Global Antituberculosis Agent-9 Sale Price by Company
3.4 Key Manufacturers Antituberculosis Agent-9 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antituberculosis Agent-9 Product Location Distribution
3.4.2 Players Antituberculosis Agent-9 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTITUBERCULOSIS AGENT-9 BY GEOGRAPHIC REGION
4.1 World Historic Antituberculosis Agent-9 Market Size by Geographic Region (2020-2025)
4.1.1 Global Antituberculosis Agent-9 Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Antituberculosis Agent-9 Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Antituberculosis Agent-9 Market Size by Country/Region (2020-2025)
4.2.1 Global Antituberculosis Agent-9 Annual Sales by Country/Region (2020-2025)
4.2.2 Global Antituberculosis Agent-9 Annual Revenue by Country/Region (2020-2025)
4.3 Americas Antituberculosis Agent-9 Sales Growth
4.4 APAC Antituberculosis Agent-9 Sales Growth
4.5 Europe Antituberculosis Agent-9 Sales Growth
4.6 Middle East & Africa Antituberculosis Agent-9 Sales Growth
5 AMERICAS
5.1 Americas Antituberculosis Agent-9 Sales by Country
5.1.1 Americas Antituberculosis Agent-9 Sales by Country (2020-2025)
5.1.2 Americas Antituberculosis Agent-9 Revenue by Country (2020-2025)
5.2 Americas Antituberculosis Agent-9 Sales by Type (2020-2025)
5.3 Americas Antituberculosis Agent-9 Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antituberculosis Agent-9 Sales by Region
6.1.1 APAC Antituberculosis Agent-9 Sales by Region (2020-2025)
6.1.2 APAC Antituberculosis Agent-9 Revenue by Region (2020-2025)
6.2 APAC Antituberculosis Agent-9 Sales by Type (2020-2025)
6.3 APAC Antituberculosis Agent-9 Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Antituberculosis Agent-9 by Country
7.1.1 Europe Antituberculosis Agent-9 Sales by Country (2020-2025)
7.1.2 Europe Antituberculosis Agent-9 Revenue by Country (2020-2025)
7.2 Europe Antituberculosis Agent-9 Sales by Type (2020-2025)
7.3 Europe Antituberculosis Agent-9 Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Antituberculosis Agent-9 by Country
8.1.1 Middle East & Africa Antituberculosis Agent-9 Sales by Country (2020-2025)
8.1.2 Middle East & Africa Antituberculosis Agent-9 Revenue by Country (2020-2025)
8.2 Middle East & Africa Antituberculosis Agent-9 Sales by Type (2020-2025)
8.3 Middle East & Africa Antituberculosis Agent-9 Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antituberculosis Agent-9
10.3 Manufacturing Process Analysis of Antituberculosis Agent-9
10.4 Industry Chain Structure of Antituberculosis Agent-9
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Antituberculosis Agent-9 Distributors
11.3 Antituberculosis Agent-9 Customer
12 WORLD FORECAST REVIEW FOR ANTITUBERCULOSIS AGENT-9 BY GEOGRAPHIC REGION
12.1 Global Antituberculosis Agent-9 Market Size Forecast by Region
12.1.1 Global Antituberculosis Agent-9 Forecast by Region (2026-2031)
12.1.2 Global Antituberculosis Agent-9 Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Antituberculosis Agent-9 Forecast by Type (2026-2031)
12.7 Global Antituberculosis Agent-9 Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 MedChemExpress
13.1.1 MedChemExpress Company Information
13.1.2 MedChemExpress Antituberculosis Agent-9 Product Portfolios and Specifications
13.1.3 MedChemExpress Antituberculosis Agent-9 Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 MedChemExpress Main Business Overview
13.1.5 MedChemExpress Latest Developments
13.2 Pfizer Inc.
13.2.1 Pfizer Inc. Company Information
13.2.2 Pfizer Inc. Antituberculosis Agent-9 Product Portfolios and Specifications
13.2.3 Pfizer Inc. Antituberculosis Agent-9 Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Pfizer Inc. Main Business Overview
13.2.5 Pfizer Inc. Latest Developments
13.3 Sanofi S.A.
13.3.1 Sanofi S.A. Company Information
13.3.2 Sanofi S.A. Antituberculosis Agent-9 Product Portfolios and Specifications
13.3.3 Sanofi S.A. Antituberculosis Agent-9 Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Sanofi S.A. Main Business Overview
13.3.5 Sanofi S.A. Latest Developments
13.4 Novartis International AG
13.4.1 Novartis International AG Company Information
13.4.2 Novartis International AG Antituberculosis Agent-9 Product Portfolios and Specifications
13.4.3 Novartis International AG Antituberculosis Agent-9 Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Novartis International AG Main Business Overview
13.4.5 Novartis International AG Latest Developments
13.5 GlaxoSmithKline plc
13.5.1 GlaxoSmithKline plc Company Information
13.5.2 GlaxoSmithKline plc Antituberculosis Agent-9 Product Portfolios and Specifications
13.5.3 GlaxoSmithKline plc Antituberculosis Agent-9 Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 GlaxoSmithKline plc Main Business Overview
13.5.5 GlaxoSmithKline plc Latest Developments
13.6 Johnson & Johnson
13.6.1 Johnson & Johnson Company Information
13.6.2 Johnson & Johnson Antituberculosis Agent-9 Product Portfolios and Specifications
13.6.3 Johnson & Johnson Antituberculosis Agent-9 Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Johnson & Johnson Main Business Overview
13.6.5 Johnson & Johnson Latest Developments
13.7 Lupin Limited
13.7.1 Lupin Limited Company Information
13.7.2 Lupin Limited Antituberculosis Agent-9 Product Portfolios and Specifications
13.7.3 Lupin Limited Antituberculosis Agent-9 Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Lupin Limited Main Business Overview
13.7.5 Lupin Limited Latest Developments
13.8 Otsuka Pharmaceutical Co., Ltd.
13.8.1 Otsuka Pharmaceutical Co., Ltd. Company Information
13.8.2 Otsuka Pharmaceutical Co., Ltd. Antituberculosis Agent-9 Product Portfolios and Specifications
13.8.3 Otsuka Pharmaceutical Co., Ltd. Antituberculosis Agent-9 Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Otsuka Pharmaceutical Co., Ltd. Main Business Overview
13.8.5 Otsuka Pharmaceutical Co., Ltd. Latest Developments
13.9 Eli Lilly and Company
13.9.1 Eli Lilly and Company Company Information
13.9.2 Eli Lilly and Company Antituberculosis Agent-9 Product Portfolios and Specifications
13.9.3 Eli Lilly and Company Antituberculosis Agent-9 Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Eli Lilly and Company Main Business Overview
13.9.5 Eli Lilly and Company Latest Developments
13.10 Sandoz International GmbH
13.10.1 Sandoz International GmbH Company Information
13.10.2 Sandoz International GmbH Antituberculosis Agent-9 Product Portfolios and Specifications
13.10.3 Sandoz International GmbH Antituberculosis Agent-9 Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Sandoz International GmbH Main Business Overview
13.10.5 Sandoz International GmbH Latest Developments
13.11 Mylan N.V.
13.11.1 Mylan N.V. Company Information
13.11.2 Mylan N.V. Antituberculosis Agent-9 Product Portfolios and Specifications
13.11.3 Mylan N.V. Antituberculosis Agent-9 Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Mylan N.V. Main Business Overview
13.11.5 Mylan N.V. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Antituberculosis Agent-9 Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Antituberculosis Agent-9 by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Antituberculosis Agent-9 by Country/Region, 2020, 2024 & 2031
2.2 Antituberculosis Agent-9 Segment by Type
2.2.1 Solid State
2.2.2 Liquid State
2.3 Antituberculosis Agent-9 Sales by Type
2.3.1 Global Antituberculosis Agent-9 Sales Market Share by Type (2020-2025)
2.3.2 Global Antituberculosis Agent-9 Revenue and Market Share by Type (2020-2025)
2.3.3 Global Antituberculosis Agent-9 Sale Price by Type (2020-2025)
2.4 Antituberculosis Agent-9 Segment by Application
2.4.1 Oral
2.4.2 Injection
2.5 Antituberculosis Agent-9 Sales by Application
2.5.1 Global Antituberculosis Agent-9 Sale Market Share by Application (2020-2025)
2.5.2 Global Antituberculosis Agent-9 Revenue and Market Share by Application (2020-2025)
2.5.3 Global Antituberculosis Agent-9 Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Antituberculosis Agent-9 Breakdown Data by Company
3.1.1 Global Antituberculosis Agent-9 Annual Sales by Company (2020-2025)
3.1.2 Global Antituberculosis Agent-9 Sales Market Share by Company (2020-2025)
3.2 Global Antituberculosis Agent-9 Annual Revenue by Company (2020-2025)
3.2.1 Global Antituberculosis Agent-9 Revenue by Company (2020-2025)
3.2.2 Global Antituberculosis Agent-9 Revenue Market Share by Company (2020-2025)
3.3 Global Antituberculosis Agent-9 Sale Price by Company
3.4 Key Manufacturers Antituberculosis Agent-9 Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antituberculosis Agent-9 Product Location Distribution
3.4.2 Players Antituberculosis Agent-9 Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTITUBERCULOSIS AGENT-9 BY GEOGRAPHIC REGION
4.1 World Historic Antituberculosis Agent-9 Market Size by Geographic Region (2020-2025)
4.1.1 Global Antituberculosis Agent-9 Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Antituberculosis Agent-9 Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Antituberculosis Agent-9 Market Size by Country/Region (2020-2025)
4.2.1 Global Antituberculosis Agent-9 Annual Sales by Country/Region (2020-2025)
4.2.2 Global Antituberculosis Agent-9 Annual Revenue by Country/Region (2020-2025)
4.3 Americas Antituberculosis Agent-9 Sales Growth
4.4 APAC Antituberculosis Agent-9 Sales Growth
4.5 Europe Antituberculosis Agent-9 Sales Growth
4.6 Middle East & Africa Antituberculosis Agent-9 Sales Growth
5 AMERICAS
5.1 Americas Antituberculosis Agent-9 Sales by Country
5.1.1 Americas Antituberculosis Agent-9 Sales by Country (2020-2025)
5.1.2 Americas Antituberculosis Agent-9 Revenue by Country (2020-2025)
5.2 Americas Antituberculosis Agent-9 Sales by Type (2020-2025)
5.3 Americas Antituberculosis Agent-9 Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antituberculosis Agent-9 Sales by Region
6.1.1 APAC Antituberculosis Agent-9 Sales by Region (2020-2025)
6.1.2 APAC Antituberculosis Agent-9 Revenue by Region (2020-2025)
6.2 APAC Antituberculosis Agent-9 Sales by Type (2020-2025)
6.3 APAC Antituberculosis Agent-9 Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Antituberculosis Agent-9 by Country
7.1.1 Europe Antituberculosis Agent-9 Sales by Country (2020-2025)
7.1.2 Europe Antituberculosis Agent-9 Revenue by Country (2020-2025)
7.2 Europe Antituberculosis Agent-9 Sales by Type (2020-2025)
7.3 Europe Antituberculosis Agent-9 Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Antituberculosis Agent-9 by Country
8.1.1 Middle East & Africa Antituberculosis Agent-9 Sales by Country (2020-2025)
8.1.2 Middle East & Africa Antituberculosis Agent-9 Revenue by Country (2020-2025)
8.2 Middle East & Africa Antituberculosis Agent-9 Sales by Type (2020-2025)
8.3 Middle East & Africa Antituberculosis Agent-9 Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antituberculosis Agent-9
10.3 Manufacturing Process Analysis of Antituberculosis Agent-9
10.4 Industry Chain Structure of Antituberculosis Agent-9
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Antituberculosis Agent-9 Distributors
11.3 Antituberculosis Agent-9 Customer
12 WORLD FORECAST REVIEW FOR ANTITUBERCULOSIS AGENT-9 BY GEOGRAPHIC REGION
12.1 Global Antituberculosis Agent-9 Market Size Forecast by Region
12.1.1 Global Antituberculosis Agent-9 Forecast by Region (2026-2031)
12.1.2 Global Antituberculosis Agent-9 Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Antituberculosis Agent-9 Forecast by Type (2026-2031)
12.7 Global Antituberculosis Agent-9 Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 MedChemExpress
13.1.1 MedChemExpress Company Information
13.1.2 MedChemExpress Antituberculosis Agent-9 Product Portfolios and Specifications
13.1.3 MedChemExpress Antituberculosis Agent-9 Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 MedChemExpress Main Business Overview
13.1.5 MedChemExpress Latest Developments
13.2 Pfizer Inc.
13.2.1 Pfizer Inc. Company Information
13.2.2 Pfizer Inc. Antituberculosis Agent-9 Product Portfolios and Specifications
13.2.3 Pfizer Inc. Antituberculosis Agent-9 Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Pfizer Inc. Main Business Overview
13.2.5 Pfizer Inc. Latest Developments
13.3 Sanofi S.A.
13.3.1 Sanofi S.A. Company Information
13.3.2 Sanofi S.A. Antituberculosis Agent-9 Product Portfolios and Specifications
13.3.3 Sanofi S.A. Antituberculosis Agent-9 Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Sanofi S.A. Main Business Overview
13.3.5 Sanofi S.A. Latest Developments
13.4 Novartis International AG
13.4.1 Novartis International AG Company Information
13.4.2 Novartis International AG Antituberculosis Agent-9 Product Portfolios and Specifications
13.4.3 Novartis International AG Antituberculosis Agent-9 Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Novartis International AG Main Business Overview
13.4.5 Novartis International AG Latest Developments
13.5 GlaxoSmithKline plc
13.5.1 GlaxoSmithKline plc Company Information
13.5.2 GlaxoSmithKline plc Antituberculosis Agent-9 Product Portfolios and Specifications
13.5.3 GlaxoSmithKline plc Antituberculosis Agent-9 Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 GlaxoSmithKline plc Main Business Overview
13.5.5 GlaxoSmithKline plc Latest Developments
13.6 Johnson & Johnson
13.6.1 Johnson & Johnson Company Information
13.6.2 Johnson & Johnson Antituberculosis Agent-9 Product Portfolios and Specifications
13.6.3 Johnson & Johnson Antituberculosis Agent-9 Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Johnson & Johnson Main Business Overview
13.6.5 Johnson & Johnson Latest Developments
13.7 Lupin Limited
13.7.1 Lupin Limited Company Information
13.7.2 Lupin Limited Antituberculosis Agent-9 Product Portfolios and Specifications
13.7.3 Lupin Limited Antituberculosis Agent-9 Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Lupin Limited Main Business Overview
13.7.5 Lupin Limited Latest Developments
13.8 Otsuka Pharmaceutical Co., Ltd.
13.8.1 Otsuka Pharmaceutical Co., Ltd. Company Information
13.8.2 Otsuka Pharmaceutical Co., Ltd. Antituberculosis Agent-9 Product Portfolios and Specifications
13.8.3 Otsuka Pharmaceutical Co., Ltd. Antituberculosis Agent-9 Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Otsuka Pharmaceutical Co., Ltd. Main Business Overview
13.8.5 Otsuka Pharmaceutical Co., Ltd. Latest Developments
13.9 Eli Lilly and Company
13.9.1 Eli Lilly and Company Company Information
13.9.2 Eli Lilly and Company Antituberculosis Agent-9 Product Portfolios and Specifications
13.9.3 Eli Lilly and Company Antituberculosis Agent-9 Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Eli Lilly and Company Main Business Overview
13.9.5 Eli Lilly and Company Latest Developments
13.10 Sandoz International GmbH
13.10.1 Sandoz International GmbH Company Information
13.10.2 Sandoz International GmbH Antituberculosis Agent-9 Product Portfolios and Specifications
13.10.3 Sandoz International GmbH Antituberculosis Agent-9 Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Sandoz International GmbH Main Business Overview
13.10.5 Sandoz International GmbH Latest Developments
13.11 Mylan N.V.
13.11.1 Mylan N.V. Company Information
13.11.2 Mylan N.V. Antituberculosis Agent-9 Product Portfolios and Specifications
13.11.3 Mylan N.V. Antituberculosis Agent-9 Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Mylan N.V. Main Business Overview
13.11.5 Mylan N.V. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Antituberculosis Agent-9 Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Antituberculosis Agent-9 Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Solid State
Table 4. Major Players of Liquid State
Table 5. Global Antituberculosis Agent-9 Sales by Type (2020-2025) & (Tons)
Table 6. Global Antituberculosis Agent-9 Sales Market Share by Type (2020-2025)
Table 7. Global Antituberculosis Agent-9 Revenue by Type (2020-2025) & ($ million)
Table 8. Global Antituberculosis Agent-9 Revenue Market Share by Type (2020-2025)
Table 9. Global Antituberculosis Agent-9 Sale Price by Type (2020-2025) & (US$/Ton)
Table 10. Global Antituberculosis Agent-9 Sale by Application (2020-2025) & (Tons)
Table 11. Global Antituberculosis Agent-9 Sale Market Share by Application (2020-2025)
Table 12. Global Antituberculosis Agent-9 Revenue by Application (2020-2025) & ($ million)
Table 13. Global Antituberculosis Agent-9 Revenue Market Share by Application (2020-2025)
Table 14. Global Antituberculosis Agent-9 Sale Price by Application (2020-2025) & (US$/Ton)
Table 15. Global Antituberculosis Agent-9 Sales by Company (2020-2025) & (Tons)
Table 16. Global Antituberculosis Agent-9 Sales Market Share by Company (2020-2025)
Table 17. Global Antituberculosis Agent-9 Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Antituberculosis Agent-9 Revenue Market Share by Company (2020-2025)
Table 19. Global Antituberculosis Agent-9 Sale Price by Company (2020-2025) & (US$/Ton)
Table 20. Key Manufacturers Antituberculosis Agent-9 Producing Area Distribution and Sales Area
Table 21. Players Antituberculosis Agent-9 Products Offered
Table 22. Antituberculosis Agent-9 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Antituberculosis Agent-9 Sales by Geographic Region (2020-2025) & (Tons)
Table 26. Global Antituberculosis Agent-9 Sales Market Share Geographic Region (2020-2025)
Table 27. Global Antituberculosis Agent-9 Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Antituberculosis Agent-9 Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Antituberculosis Agent-9 Sales by Country/Region (2020-2025) & (Tons)
Table 30. Global Antituberculosis Agent-9 Sales Market Share by Country/Region (2020-2025)
Table 31. Global Antituberculosis Agent-9 Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Antituberculosis Agent-9 Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Antituberculosis Agent-9 Sales by Country (2020-2025) & (Tons)
Table 34. Americas Antituberculosis Agent-9 Sales Market Share by Country (2020-2025)
Table 35. Americas Antituberculosis Agent-9 Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Antituberculosis Agent-9 Sales by Type (2020-2025) & (Tons)
Table 37. Americas Antituberculosis Agent-9 Sales by Application (2020-2025) & (Tons)
Table 38. APAC Antituberculosis Agent-9 Sales by Region (2020-2025) & (Tons)
Table 39. APAC Antituberculosis Agent-9 Sales Market Share by Region (2020-2025)
Table 40. APAC Antituberculosis Agent-9 Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Antituberculosis Agent-9 Sales by Type (2020-2025) & (Tons)
Table 42. APAC Antituberculosis Agent-9 Sales by Application (2020-2025) & (Tons)
Table 43. Europe Antituberculosis Agent-9 Sales by Country (2020-2025) & (Tons)
Table 44. Europe Antituberculosis Agent-9 Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Antituberculosis Agent-9 Sales by Type (2020-2025) & (Tons)
Table 46. Europe Antituberculosis Agent-9 Sales by Application (2020-2025) & (Tons)
Table 47. Middle East & Africa Antituberculosis Agent-9 Sales by Country (2020-2025) & (Tons)
Table 48. Middle East & Africa Antituberculosis Agent-9 Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Antituberculosis Agent-9 Sales by Type (2020-2025) & (Tons)
Table 50. Middle East & Africa Antituberculosis Agent-9 Sales by Application (2020-2025) & (Tons)
Table 51. Key Market Drivers & Growth Opportunities of Antituberculosis Agent-9
Table 52. Key Market Challenges & Risks of Antituberculosis Agent-9
Table 53. Key Industry Trends of Antituberculosis Agent-9
Table 54. Antituberculosis Agent-9 Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Antituberculosis Agent-9 Distributors List
Table 57. Antituberculosis Agent-9 Customer List
Table 58. Global Antituberculosis Agent-9 Sales Forecast by Region (2026-2031) & (Tons)
Table 59. Global Antituberculosis Agent-9 Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Antituberculosis Agent-9 Sales Forecast by Country (2026-2031) & (Tons)
Table 61. Americas Antituberculosis Agent-9 Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Antituberculosis Agent-9 Sales Forecast by Region (2026-2031) & (Tons)
Table 63. APAC Antituberculosis Agent-9 Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Antituberculosis Agent-9 Sales Forecast by Country (2026-2031) & (Tons)
Table 65. Europe Antituberculosis Agent-9 Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Antituberculosis Agent-9 Sales Forecast by Country (2026-2031) & (Tons)
Table 67. Middle East & Africa Antituberculosis Agent-9 Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Antituberculosis Agent-9 Sales Forecast by Type (2026-2031) & (Tons)
Table 69. Global Antituberculosis Agent-9 Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Antituberculosis Agent-9 Sales Forecast by Application (2026-2031) & (Tons)
Table 71. Global Antituberculosis Agent-9 Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. MedChemExpress Basic Information, Antituberculosis Agent-9 Manufacturing Base, Sales Area and Its Competitors
Table 73. MedChemExpress Antituberculosis Agent-9 Product Portfolios and Specifications
Table 74. MedChemExpress Antituberculosis Agent-9 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 75. MedChemExpress Main Business
Table 76. MedChemExpress Latest Developments
Table 77. Pfizer Inc. Basic Information, Antituberculosis Agent-9 Manufacturing Base, Sales Area and Its Competitors
Table 78. Pfizer Inc. Antituberculosis Agent-9 Product Portfolios and Specifications
Table 79. Pfizer Inc. Antituberculosis Agent-9 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 80. Pfizer Inc. Main Business
Table 81. Pfizer Inc. Latest Developments
Table 82. Sanofi S.A. Basic Information, Antituberculosis Agent-9 Manufacturing Base, Sales Area and Its Competitors
Table 83. Sanofi S.A. Antituberculosis Agent-9 Product Portfolios and Specifications
Table 84. Sanofi S.A. Antituberculosis Agent-9 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 85. Sanofi S.A. Main Business
Table 86. Sanofi S.A. Latest Developments
Table 87. Novartis International AG Basic Information, Antituberculosis Agent-9 Manufacturing Base, Sales Area and Its Competitors
Table 88. Novartis International AG Antituberculosis Agent-9 Product Portfolios and Specifications
Table 89. Novartis International AG Antituberculosis Agent-9 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 90. Novartis International AG Main Business
Table 91. Novartis International AG Latest Developments
Table 92. GlaxoSmithKline plc Basic Information, Antituberculosis Agent-9 Manufacturing Base, Sales Area and Its Competitors
Table 93. GlaxoSmithKline plc Antituberculosis Agent-9 Product Portfolios and Specifications
Table 94. GlaxoSmithKline plc Antituberculosis Agent-9 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 95. GlaxoSmithKline plc Main Business
Table 96. GlaxoSmithKline plc Latest Developments
Table 97. Johnson & Johnson Basic Information, Antituberculosis Agent-9 Manufacturing Base, Sales Area and Its Competitors
Table 98. Johnson & Johnson Antituberculosis Agent-9 Product Portfolios and Specifications
Table 99. Johnson & Johnson Antituberculosis Agent-9 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 100. Johnson & Johnson Main Business
Table 101. Johnson & Johnson Latest Developments
Table 102. Lupin Limited Basic Information, Antituberculosis Agent-9 Manufacturing Base, Sales Area and Its Competitors
Table 103. Lupin Limited Antituberculosis Agent-9 Product Portfolios and Specifications
Table 104. Lupin Limited Antituberculosis Agent-9 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 105. Lupin Limited Main Business
Table 106. Lupin Limited Latest Developments
Table 107. Otsuka Pharmaceutical Co., Ltd. Basic Information, Antituberculosis Agent-9 Manufacturing Base, Sales Area and Its Competitors
Table 108. Otsuka Pharmaceutical Co., Ltd. Antituberculosis Agent-9 Product Portfolios and Specifications
Table 109. Otsuka Pharmaceutical Co., Ltd. Antituberculosis Agent-9 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 110. Otsuka Pharmaceutical Co., Ltd. Main Business
Table 111. Otsuka Pharmaceutical Co., Ltd. Latest Developments
Table 112. Eli Lilly and Company Basic Information, Antituberculosis Agent-9 Manufacturing Base, Sales Area and Its Competitors
Table 113. Eli Lilly and Company Antituberculosis Agent-9 Product Portfolios and Specifications
Table 114. Eli Lilly and Company Antituberculosis Agent-9 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 115. Eli Lilly and Company Main Business
Table 116. Eli Lilly and Company Latest Developments
Table 117. Sandoz International GmbH Basic Information, Antituberculosis Agent-9 Manufacturing Base, Sales Area and Its Competitors
Table 118. Sandoz International GmbH Antituberculosis Agent-9 Product Portfolios and Specifications
Table 119. Sandoz International GmbH Antituberculosis Agent-9 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 120. Sandoz International GmbH Main Business
Table 121. Sandoz International GmbH Latest Developments
Table 122. Mylan N.V. Basic Information, Antituberculosis Agent-9 Manufacturing Base, Sales Area and Its Competitors
Table 123. Mylan N.V. Antituberculosis Agent-9 Product Portfolios and Specifications
Table 124. Mylan N.V. Antituberculosis Agent-9 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 125. Mylan N.V. Main Business
Table 126. Mylan N.V. Latest Developments
Table 1. Antituberculosis Agent-9 Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Antituberculosis Agent-9 Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Solid State
Table 4. Major Players of Liquid State
Table 5. Global Antituberculosis Agent-9 Sales by Type (2020-2025) & (Tons)
Table 6. Global Antituberculosis Agent-9 Sales Market Share by Type (2020-2025)
Table 7. Global Antituberculosis Agent-9 Revenue by Type (2020-2025) & ($ million)
Table 8. Global Antituberculosis Agent-9 Revenue Market Share by Type (2020-2025)
Table 9. Global Antituberculosis Agent-9 Sale Price by Type (2020-2025) & (US$/Ton)
Table 10. Global Antituberculosis Agent-9 Sale by Application (2020-2025) & (Tons)
Table 11. Global Antituberculosis Agent-9 Sale Market Share by Application (2020-2025)
Table 12. Global Antituberculosis Agent-9 Revenue by Application (2020-2025) & ($ million)
Table 13. Global Antituberculosis Agent-9 Revenue Market Share by Application (2020-2025)
Table 14. Global Antituberculosis Agent-9 Sale Price by Application (2020-2025) & (US$/Ton)
Table 15. Global Antituberculosis Agent-9 Sales by Company (2020-2025) & (Tons)
Table 16. Global Antituberculosis Agent-9 Sales Market Share by Company (2020-2025)
Table 17. Global Antituberculosis Agent-9 Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Antituberculosis Agent-9 Revenue Market Share by Company (2020-2025)
Table 19. Global Antituberculosis Agent-9 Sale Price by Company (2020-2025) & (US$/Ton)
Table 20. Key Manufacturers Antituberculosis Agent-9 Producing Area Distribution and Sales Area
Table 21. Players Antituberculosis Agent-9 Products Offered
Table 22. Antituberculosis Agent-9 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Antituberculosis Agent-9 Sales by Geographic Region (2020-2025) & (Tons)
Table 26. Global Antituberculosis Agent-9 Sales Market Share Geographic Region (2020-2025)
Table 27. Global Antituberculosis Agent-9 Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Antituberculosis Agent-9 Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Antituberculosis Agent-9 Sales by Country/Region (2020-2025) & (Tons)
Table 30. Global Antituberculosis Agent-9 Sales Market Share by Country/Region (2020-2025)
Table 31. Global Antituberculosis Agent-9 Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Antituberculosis Agent-9 Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Antituberculosis Agent-9 Sales by Country (2020-2025) & (Tons)
Table 34. Americas Antituberculosis Agent-9 Sales Market Share by Country (2020-2025)
Table 35. Americas Antituberculosis Agent-9 Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Antituberculosis Agent-9 Sales by Type (2020-2025) & (Tons)
Table 37. Americas Antituberculosis Agent-9 Sales by Application (2020-2025) & (Tons)
Table 38. APAC Antituberculosis Agent-9 Sales by Region (2020-2025) & (Tons)
Table 39. APAC Antituberculosis Agent-9 Sales Market Share by Region (2020-2025)
Table 40. APAC Antituberculosis Agent-9 Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Antituberculosis Agent-9 Sales by Type (2020-2025) & (Tons)
Table 42. APAC Antituberculosis Agent-9 Sales by Application (2020-2025) & (Tons)
Table 43. Europe Antituberculosis Agent-9 Sales by Country (2020-2025) & (Tons)
Table 44. Europe Antituberculosis Agent-9 Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Antituberculosis Agent-9 Sales by Type (2020-2025) & (Tons)
Table 46. Europe Antituberculosis Agent-9 Sales by Application (2020-2025) & (Tons)
Table 47. Middle East & Africa Antituberculosis Agent-9 Sales by Country (2020-2025) & (Tons)
Table 48. Middle East & Africa Antituberculosis Agent-9 Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Antituberculosis Agent-9 Sales by Type (2020-2025) & (Tons)
Table 50. Middle East & Africa Antituberculosis Agent-9 Sales by Application (2020-2025) & (Tons)
Table 51. Key Market Drivers & Growth Opportunities of Antituberculosis Agent-9
Table 52. Key Market Challenges & Risks of Antituberculosis Agent-9
Table 53. Key Industry Trends of Antituberculosis Agent-9
Table 54. Antituberculosis Agent-9 Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Antituberculosis Agent-9 Distributors List
Table 57. Antituberculosis Agent-9 Customer List
Table 58. Global Antituberculosis Agent-9 Sales Forecast by Region (2026-2031) & (Tons)
Table 59. Global Antituberculosis Agent-9 Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Antituberculosis Agent-9 Sales Forecast by Country (2026-2031) & (Tons)
Table 61. Americas Antituberculosis Agent-9 Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Antituberculosis Agent-9 Sales Forecast by Region (2026-2031) & (Tons)
Table 63. APAC Antituberculosis Agent-9 Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Antituberculosis Agent-9 Sales Forecast by Country (2026-2031) & (Tons)
Table 65. Europe Antituberculosis Agent-9 Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Antituberculosis Agent-9 Sales Forecast by Country (2026-2031) & (Tons)
Table 67. Middle East & Africa Antituberculosis Agent-9 Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Antituberculosis Agent-9 Sales Forecast by Type (2026-2031) & (Tons)
Table 69. Global Antituberculosis Agent-9 Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Antituberculosis Agent-9 Sales Forecast by Application (2026-2031) & (Tons)
Table 71. Global Antituberculosis Agent-9 Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. MedChemExpress Basic Information, Antituberculosis Agent-9 Manufacturing Base, Sales Area and Its Competitors
Table 73. MedChemExpress Antituberculosis Agent-9 Product Portfolios and Specifications
Table 74. MedChemExpress Antituberculosis Agent-9 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 75. MedChemExpress Main Business
Table 76. MedChemExpress Latest Developments
Table 77. Pfizer Inc. Basic Information, Antituberculosis Agent-9 Manufacturing Base, Sales Area and Its Competitors
Table 78. Pfizer Inc. Antituberculosis Agent-9 Product Portfolios and Specifications
Table 79. Pfizer Inc. Antituberculosis Agent-9 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 80. Pfizer Inc. Main Business
Table 81. Pfizer Inc. Latest Developments
Table 82. Sanofi S.A. Basic Information, Antituberculosis Agent-9 Manufacturing Base, Sales Area and Its Competitors
Table 83. Sanofi S.A. Antituberculosis Agent-9 Product Portfolios and Specifications
Table 84. Sanofi S.A. Antituberculosis Agent-9 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 85. Sanofi S.A. Main Business
Table 86. Sanofi S.A. Latest Developments
Table 87. Novartis International AG Basic Information, Antituberculosis Agent-9 Manufacturing Base, Sales Area and Its Competitors
Table 88. Novartis International AG Antituberculosis Agent-9 Product Portfolios and Specifications
Table 89. Novartis International AG Antituberculosis Agent-9 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 90. Novartis International AG Main Business
Table 91. Novartis International AG Latest Developments
Table 92. GlaxoSmithKline plc Basic Information, Antituberculosis Agent-9 Manufacturing Base, Sales Area and Its Competitors
Table 93. GlaxoSmithKline plc Antituberculosis Agent-9 Product Portfolios and Specifications
Table 94. GlaxoSmithKline plc Antituberculosis Agent-9 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 95. GlaxoSmithKline plc Main Business
Table 96. GlaxoSmithKline plc Latest Developments
Table 97. Johnson & Johnson Basic Information, Antituberculosis Agent-9 Manufacturing Base, Sales Area and Its Competitors
Table 98. Johnson & Johnson Antituberculosis Agent-9 Product Portfolios and Specifications
Table 99. Johnson & Johnson Antituberculosis Agent-9 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 100. Johnson & Johnson Main Business
Table 101. Johnson & Johnson Latest Developments
Table 102. Lupin Limited Basic Information, Antituberculosis Agent-9 Manufacturing Base, Sales Area and Its Competitors
Table 103. Lupin Limited Antituberculosis Agent-9 Product Portfolios and Specifications
Table 104. Lupin Limited Antituberculosis Agent-9 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 105. Lupin Limited Main Business
Table 106. Lupin Limited Latest Developments
Table 107. Otsuka Pharmaceutical Co., Ltd. Basic Information, Antituberculosis Agent-9 Manufacturing Base, Sales Area and Its Competitors
Table 108. Otsuka Pharmaceutical Co., Ltd. Antituberculosis Agent-9 Product Portfolios and Specifications
Table 109. Otsuka Pharmaceutical Co., Ltd. Antituberculosis Agent-9 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 110. Otsuka Pharmaceutical Co., Ltd. Main Business
Table 111. Otsuka Pharmaceutical Co., Ltd. Latest Developments
Table 112. Eli Lilly and Company Basic Information, Antituberculosis Agent-9 Manufacturing Base, Sales Area and Its Competitors
Table 113. Eli Lilly and Company Antituberculosis Agent-9 Product Portfolios and Specifications
Table 114. Eli Lilly and Company Antituberculosis Agent-9 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 115. Eli Lilly and Company Main Business
Table 116. Eli Lilly and Company Latest Developments
Table 117. Sandoz International GmbH Basic Information, Antituberculosis Agent-9 Manufacturing Base, Sales Area and Its Competitors
Table 118. Sandoz International GmbH Antituberculosis Agent-9 Product Portfolios and Specifications
Table 119. Sandoz International GmbH Antituberculosis Agent-9 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 120. Sandoz International GmbH Main Business
Table 121. Sandoz International GmbH Latest Developments
Table 122. Mylan N.V. Basic Information, Antituberculosis Agent-9 Manufacturing Base, Sales Area and Its Competitors
Table 123. Mylan N.V. Antituberculosis Agent-9 Product Portfolios and Specifications
Table 124. Mylan N.V. Antituberculosis Agent-9 Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 125. Mylan N.V. Main Business
Table 126. Mylan N.V. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Antituberculosis Agent-9
Figure 2. Antituberculosis Agent-9 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antituberculosis Agent-9 Sales Growth Rate 2020-2031 (Tons)
Figure 7. Global Antituberculosis Agent-9 Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Antituberculosis Agent-9 Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Antituberculosis Agent-9 Sales Market Share by Country/Region (2024)
Figure 10. Antituberculosis Agent-9 Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Solid State
Figure 12. Product Picture of Liquid State
Figure 13. Global Antituberculosis Agent-9 Sales Market Share by Type in 2025
Figure 14. Global Antituberculosis Agent-9 Revenue Market Share by Type (2020-2025)
Figure 15. Antituberculosis Agent-9 Consumed in Oral
Figure 16. Global Antituberculosis Agent-9 Market: Oral (2020-2025) & (Tons)
Figure 17. Antituberculosis Agent-9 Consumed in Injection
Figure 18. Global Antituberculosis Agent-9 Market: Injection (2020-2025) & (Tons)
Figure 19. Global Antituberculosis Agent-9 Sale Market Share by Application (2024)
Figure 20. Global Antituberculosis Agent-9 Revenue Market Share by Application in 2025
Figure 21. Antituberculosis Agent-9 Sales by Company in 2025 (Tons)
Figure 22. Global Antituberculosis Agent-9 Sales Market Share by Company in 2025
Figure 23. Antituberculosis Agent-9 Revenue by Company in 2025 ($ millions)
Figure 24. Global Antituberculosis Agent-9 Revenue Market Share by Company in 2025
Figure 25. Global Antituberculosis Agent-9 Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Antituberculosis Agent-9 Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Antituberculosis Agent-9 Sales 2020-2025 (Tons)
Figure 28. Americas Antituberculosis Agent-9 Revenue 2020-2025 ($ millions)
Figure 29. APAC Antituberculosis Agent-9 Sales 2020-2025 (Tons)
Figure 30. APAC Antituberculosis Agent-9 Revenue 2020-2025 ($ millions)
Figure 31. Europe Antituberculosis Agent-9 Sales 2020-2025 (Tons)
Figure 32. Europe Antituberculosis Agent-9 Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Antituberculosis Agent-9 Sales 2020-2025 (Tons)
Figure 34. Middle East & Africa Antituberculosis Agent-9 Revenue 2020-2025 ($ millions)
Figure 35. Americas Antituberculosis Agent-9 Sales Market Share by Country in 2025
Figure 36. Americas Antituberculosis Agent-9 Revenue Market Share by Country (2020-2025)
Figure 37. Americas Antituberculosis Agent-9 Sales Market Share by Type (2020-2025)
Figure 38. Americas Antituberculosis Agent-9 Sales Market Share by Application (2020-2025)
Figure 39. United States Antituberculosis Agent-9 Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Antituberculosis Agent-9 Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Antituberculosis Agent-9 Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Antituberculosis Agent-9 Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Antituberculosis Agent-9 Sales Market Share by Region in 2025
Figure 44. APAC Antituberculosis Agent-9 Revenue Market Share by Region (2020-2025)
Figure 45. APAC Antituberculosis Agent-9 Sales Market Share by Type (2020-2025)
Figure 46. APAC Antituberculosis Agent-9 Sales Market Share by Application (2020-2025)
Figure 47. China Antituberculosis Agent-9 Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Antituberculosis Agent-9 Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Antituberculosis Agent-9 Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Antituberculosis Agent-9 Revenue Growth 2020-2025 ($ millions)
Figure 51. India Antituberculosis Agent-9 Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Antituberculosis Agent-9 Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Antituberculosis Agent-9 Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Antituberculosis Agent-9 Sales Market Share by Country in 2025
Figure 55. Europe Antituberculosis Agent-9 Revenue Market Share by Country (2020-2025)
Figure 56. Europe Antituberculosis Agent-9 Sales Market Share by Type (2020-2025)
Figure 57. Europe Antituberculosis Agent-9 Sales Market Share by Application (2020-2025)
Figure 58. Germany Antituberculosis Agent-9 Revenue Growth 2020-2025 ($ millions)
Figure 59. France Antituberculosis Agent-9 Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Antituberculosis Agent-9 Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Antituberculosis Agent-9 Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Antituberculosis Agent-9 Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Antituberculosis Agent-9 Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Antituberculosis Agent-9 Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Antituberculosis Agent-9 Sales Market Share by Application (2020-2025)
Figure 66. Egypt Antituberculosis Agent-9 Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Antituberculosis Agent-9 Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Antituberculosis Agent-9 Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Antituberculosis Agent-9 Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Antituberculosis Agent-9 Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Antituberculosis Agent-9 in 2025
Figure 72. Manufacturing Process Analysis of Antituberculosis Agent-9
Figure 73. Industry Chain Structure of Antituberculosis Agent-9
Figure 74. Channels of Distribution
Figure 75. Global Antituberculosis Agent-9 Sales Market Forecast by Region (2026-2031)
Figure 76. Global Antituberculosis Agent-9 Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Antituberculosis Agent-9 Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Antituberculosis Agent-9 Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Antituberculosis Agent-9 Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Antituberculosis Agent-9 Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Antituberculosis Agent-9
Figure 2. Antituberculosis Agent-9 Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antituberculosis Agent-9 Sales Growth Rate 2020-2031 (Tons)
Figure 7. Global Antituberculosis Agent-9 Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Antituberculosis Agent-9 Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Antituberculosis Agent-9 Sales Market Share by Country/Region (2024)
Figure 10. Antituberculosis Agent-9 Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Solid State
Figure 12. Product Picture of Liquid State
Figure 13. Global Antituberculosis Agent-9 Sales Market Share by Type in 2025
Figure 14. Global Antituberculosis Agent-9 Revenue Market Share by Type (2020-2025)
Figure 15. Antituberculosis Agent-9 Consumed in Oral
Figure 16. Global Antituberculosis Agent-9 Market: Oral (2020-2025) & (Tons)
Figure 17. Antituberculosis Agent-9 Consumed in Injection
Figure 18. Global Antituberculosis Agent-9 Market: Injection (2020-2025) & (Tons)
Figure 19. Global Antituberculosis Agent-9 Sale Market Share by Application (2024)
Figure 20. Global Antituberculosis Agent-9 Revenue Market Share by Application in 2025
Figure 21. Antituberculosis Agent-9 Sales by Company in 2025 (Tons)
Figure 22. Global Antituberculosis Agent-9 Sales Market Share by Company in 2025
Figure 23. Antituberculosis Agent-9 Revenue by Company in 2025 ($ millions)
Figure 24. Global Antituberculosis Agent-9 Revenue Market Share by Company in 2025
Figure 25. Global Antituberculosis Agent-9 Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Antituberculosis Agent-9 Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Antituberculosis Agent-9 Sales 2020-2025 (Tons)
Figure 28. Americas Antituberculosis Agent-9 Revenue 2020-2025 ($ millions)
Figure 29. APAC Antituberculosis Agent-9 Sales 2020-2025 (Tons)
Figure 30. APAC Antituberculosis Agent-9 Revenue 2020-2025 ($ millions)
Figure 31. Europe Antituberculosis Agent-9 Sales 2020-2025 (Tons)
Figure 32. Europe Antituberculosis Agent-9 Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Antituberculosis Agent-9 Sales 2020-2025 (Tons)
Figure 34. Middle East & Africa Antituberculosis Agent-9 Revenue 2020-2025 ($ millions)
Figure 35. Americas Antituberculosis Agent-9 Sales Market Share by Country in 2025
Figure 36. Americas Antituberculosis Agent-9 Revenue Market Share by Country (2020-2025)
Figure 37. Americas Antituberculosis Agent-9 Sales Market Share by Type (2020-2025)
Figure 38. Americas Antituberculosis Agent-9 Sales Market Share by Application (2020-2025)
Figure 39. United States Antituberculosis Agent-9 Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Antituberculosis Agent-9 Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Antituberculosis Agent-9 Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Antituberculosis Agent-9 Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Antituberculosis Agent-9 Sales Market Share by Region in 2025
Figure 44. APAC Antituberculosis Agent-9 Revenue Market Share by Region (2020-2025)
Figure 45. APAC Antituberculosis Agent-9 Sales Market Share by Type (2020-2025)
Figure 46. APAC Antituberculosis Agent-9 Sales Market Share by Application (2020-2025)
Figure 47. China Antituberculosis Agent-9 Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Antituberculosis Agent-9 Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Antituberculosis Agent-9 Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Antituberculosis Agent-9 Revenue Growth 2020-2025 ($ millions)
Figure 51. India Antituberculosis Agent-9 Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Antituberculosis Agent-9 Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Antituberculosis Agent-9 Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Antituberculosis Agent-9 Sales Market Share by Country in 2025
Figure 55. Europe Antituberculosis Agent-9 Revenue Market Share by Country (2020-2025)
Figure 56. Europe Antituberculosis Agent-9 Sales Market Share by Type (2020-2025)
Figure 57. Europe Antituberculosis Agent-9 Sales Market Share by Application (2020-2025)
Figure 58. Germany Antituberculosis Agent-9 Revenue Growth 2020-2025 ($ millions)
Figure 59. France Antituberculosis Agent-9 Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Antituberculosis Agent-9 Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Antituberculosis Agent-9 Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Antituberculosis Agent-9 Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Antituberculosis Agent-9 Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Antituberculosis Agent-9 Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Antituberculosis Agent-9 Sales Market Share by Application (2020-2025)
Figure 66. Egypt Antituberculosis Agent-9 Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Antituberculosis Agent-9 Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Antituberculosis Agent-9 Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Antituberculosis Agent-9 Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Antituberculosis Agent-9 Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Antituberculosis Agent-9 in 2025
Figure 72. Manufacturing Process Analysis of Antituberculosis Agent-9
Figure 73. Industry Chain Structure of Antituberculosis Agent-9
Figure 74. Channels of Distribution
Figure 75. Global Antituberculosis Agent-9 Sales Market Forecast by Region (2026-2031)
Figure 76. Global Antituberculosis Agent-9 Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Antituberculosis Agent-9 Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Antituberculosis Agent-9 Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Antituberculosis Agent-9 Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Antituberculosis Agent-9 Revenue Market Share Forecast by Application (2026-2031)
